PTC Therapeutics | PTCT - Trade Creditors

Stock Price
73.22
Daily Change
-1.61 -2.15%
Monthly
-4.61%
Yearly
46.47%
Q1 Forecast
73.20

PTC Therapeutics reported $36.62M in Trade Creditors for its fiscal quarter ending in September of 2025.





Trade Creditors Change Date
Acadia Pharmaceuticals USD 21.75M 1.65M Sep/2025
Alnylam Pharmaceuticals USD 117.59M 15.2M Sep/2025
Amgen USD 19.64B 1.61B Sep/2025
Biogen USD 413.1M 4.7M Sep/2025
BioMarin Pharmaceutical USD 798.44M 114.19M Sep/2025
Cytokinetics USD 22.08M 46.46M Sep/2025
Daiichi Sankyo JPY 568.5B 16.84B Dec/2025
Gilead Sciences USD 808M 226M Sep/2025
Incyte USD 171.92M 1.24B Sep/2025
Ionis Pharmaceuticals USD 14.33M 8.47M Sep/2025
Ironwood Pharmaceuticals USD 1.61M 224K Sep/2025
Novartis USD 4.56B 49M Sep/2025
Pfizer USD 5.02B 142M Sep/2025
PTC Therapeutics USD 36.62M 169.69M Sep/2025
Roche Holding CHF 5.78B 1.27B Dec/2025
Sarepta Therapeutics USD 94.02M 42.69M Sep/2025
TG Therapeutics USD 61.64M 72.38M Sep/2025
Ultragenyx Pharmaceutical USD 40.57M 6.33M Sep/2025
Vertex Pharmaceuticals USD 4.03B 320.8M Sep/2025
Xencor USD 9.08M 9.45M Sep/2025